- Retatrutide is a new treatment for those who are overweight or living with obesity
- The medication has not yet received approval or become available
- It works by targeting three different receptors at the same time
- Clinical trials to date suggest potential weight loss of up to 24%
- Side effects seem to be similar to those seen with other GLP-1 medications

About Retatrutide
Retatrutide: new weight loss medication in development
Retatrutide is a new medication that is currently attracting considerable attention as a potential treatment for overweight and obesity. It belongs to a new generation of drugs that are demonstrating promising results in research. Retatrutide is not yet approved or available at present. As soon as this changes, we will keep you updated.
What is Retatrutide?
- Retatrutide is a GLP-1/GIP/GCGR agonist that is currently under development.
- Clinical studies suggest it may aid weight loss and help regulate blood sugar levels.
- Its mechanism of action appears to be partly similar to established agents such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), but retatrutide targets three receptors at once.
- The drug remains in the research phase and has not yet been approved for use in Europe.
Mechanism of action of Retatrutide
Retatrutide targets three receptors (GLP-1, GIP, and GCGR) which play a role in appetite, metabolism, and the regulation of blood sugar. Studies indicate that this may potentially result in weight loss and improved glucose levels. As the medication is still under development, the precise effects, dosages, and long-term outcomes have yet to be determined.
Side effects of Retatrutide
In clinical trials, side effects have been reported which are similar to those seen with other GLP-1 agents, including:
- Nausea
- Diarrhoea
- Fatigue
As Retatrutide is still under development, a comprehensive overview of potential side effects is not yet available. This information will be updated here as more data become available.
Research on Retatrutide
Retatrutide is currently in phase 3 of clinical development. Several large-scale studies are underway across the globe, including the so-called TRIUMPH trials conducted by manufacturer Eli Lilly. These studies are examining the effects of Retatrutide in individuals with obesity, type 2 diabetes, and other conditions. Further information is available on Eli Lilly’s official trial page.
Preliminary findings from a phase 2 study, published in the New England Journal of Medicine, indicate promising outcomes:
- An average weight loss of up to 24% after 48 weeks of treatment.
- Improvements in blood glucose levels and other cardiometabolic risk factors.
- The most frequently reported side effects were mild and comparable to those seen with other GLP-1-like agents (such as nausea and diarrhoea).
These studies are ongoing. As soon as more definitive results are released, we will update this page.
Status and availability of Retatrutide
- Retatrutide has not yet been approved in Europe.
- At present, there is no clarity regarding its authorisation or availability.
- As soon as this changes, we will publish the latest information here.
What can you do now?
- Keep following this page for the latest updates on Retatrutide.
- Explore alternative weight loss treatments that are available: Wegovy.
You know perfectly well what's good and what isn't good for you. Nevertheless, making the right choice can be difficult. We are Doctoronline. We believe in self-management when it comes to your health.
Would highly recommend
It was so easy to use this service. Communication was excellent. Medication arrived in days. Would highly recommend.
Great service
Used Doctoronline on a number of occasions, always had a very good service, and quick delivery, so i highly recommend them to anyone, looking to order medication online
Fantastic & prompt service,definitely…
Fantastic & prompt service,definitely recommend
Excellent
Excellent, professional service. Reliable and fast delivery
So straight forward and easy to use
So straight forward and easy to use, fast service and great communication, was able to get treatment with out taking time off work
Super easy service
Super easy service, good communication and good advice. Medication always arrives promptly as well.
Excellent confidential experience
Very professional service.
Discretion and professionalism
Discretion and professionalism, like always, they really take care of you.
Very easy,good service
If you’re honest with Doctoronline you get a good service that’s reasonably priced and a quick delivery.I’m very happy with the service
Excellent straight forward getting…
Excellent straight forward getting prescription. Fast delivery. Happy with the service will use again.
Easy to use
Easy to use, a little overpriced.
The best consultation and good service
The best consultation and good service
Great service
Great service
Efficient and fast
Consultation comprehensive but fairly easy. Whole process efficient and fast . Recommended
When i need medication with no nonsense…
When i need medication with no nonsense these professionals deliver. I get better meds for Athma than those recommended by the NHS and they are not steroids and work very effectively. Also the range of choices are so upto date many GPS are not aware of what's really available like Doctoronline. They are top rate and delivery is excellent.
Very good service
Very good service. Fast and efficient.
thanks again doctoronline,my…
thanks again doctoronline,my prescription was processed and delivered very quickly,an excellent service,
Pump and hassle S deliveries
Pump and hassle S deliveries
Great Support When I Needed It Most
The service was efficient, easy to use, and saved me time compared to a traditional GP visit. The platform was user-friendly, the consultation process was smooth, and the healthcare professional I spoke with was knowledgeable, respectful, and attentive. I appreciated the convenience of accessing medical advice from home and the fast turnaround on my prescription and treatment plan.
Prompt and reliable service and…
Prompt and reliable service and delivery.